(Q73793658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

E Touboul

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Belkacémi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Buffat

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

E Deniaud-Alexandre

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J P Lefranc

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Lhuillier

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Uzan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Jannet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Uzan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Antoine

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Huart

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

V Ganansia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Milliez

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J Blondon

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Housset

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Schlienger

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 May 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

81-97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Operative treatment in stage I endometrial carcinoma with deep myometrial invasion and/or grade 3 tumor surgically limited to the corpus uteri. No recurrence with only primary surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Clinical Stage I adenocarcinoma of the endometrium—Analysis of recurrences and the potential benefit of staging lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Surgery without radiotherapy for primary treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

The management of clinical stage I endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Preoperative whole pelvic external irradiation in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Preoperative radiation therapy in stage I. Endometrial adenocarcinoma II. final report of a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Analysis of preoperative intracavitary cesium application versus postoperative external beam radiation in stage I endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Clinical stage I endometrial cancer: results of adjuvant irradiation and patterns of failure

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Preoperative radiotherapy and surgery for endometrial carcinoma: prognostic significance of the sterilization of the specimen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Preoperative radiation therapy followed by extrafascial hysterectomy in patients with stage II endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Primary radiation therapy for endometrial carcinoma: a case controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Clinical (stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Results of therapy, analysis of failures, and prognostic factors for clinical and pathologic stage III adenocarcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

LENT SOMA scales for all anatomic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Tumor size in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Low-stage clear-cell carcinoma of the endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Which prognostic factors influence the outcome of patients with surgically staged endometrial cancer treated with adjuvant radiation?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Uterine papillary serous carcinoma. A clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Uterine papillary serous carcinoma. Complete response to combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

[Low-dose postoperative vaginal brachytherapy of adenocarcinoma of the endometrium]

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

The justification for a surgical staging system in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Pathological prognostic factors in a series of 137 stage I TNM/UICC endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Postoperative high dose-rate intravaginal brachytherapy combined with external irradiation for early stage endometrial cancer: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Postoperative radiation therapy for surgically staged endometrial cancer: impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Analysis of complications in patients with endometrial carcinoma receiving adjuvant irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Improved outcome in patients treated with postoperative radiation therapy for pathologic stage I/II endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

The prognostic significance of vascular invasion by endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Aggressive stage I grade 1 endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Angiogenesis in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Endometrial carcinoma: does the addition of intracavitary vault caesium to external beam therapy postoperatively result in improved control or increased morbidity?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Adenocarcinoma of the Endometrium: Survival Comparisons of Patients with and without Pelvic Node Sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Radiation therapy for surgically proven para-aortic node metastasis in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Survival in patients with paraaortic lymph node metastases from endometrial adenocarcinoma clinically limited to the uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

High-dose-rate postoperative vaginal cuff irradiation alone for stage IB and IC endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Endometrial carcinoma--relative effectiveness of adjuvant irradiation vs therapy reserved for relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Stage I corpus cancer: is teletherapy necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Aspects of surgery in ovarian and endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

A randomized trial of adjuvant progestagen in early endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2901571-6

7 January 2021

10.1016/S0360-3016(00)01571-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11316550%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference